Amgen Cash Flow Overview
| AMGN Stock | USD 271.91 2.98 1.11% |
Amgen |
Most accounts from Amgen's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Amgen Inc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Amgen Valuation and Amgen Correlation analysis. At this time, Amgen's End Period Cash Flow is very stable compared to the past year. As of the 23rd of April 2024, Sale Purchase Of Stock is likely to grow to 0.00, while Free Cash Flow is likely to drop about 4.5 B.
Amgen cash flow statement Correlations
Click cells to compare fundamentals
Amgen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Amgen cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (66M) | (215M) | (165M) | (742M) | 491M | 515.6M | |
| Change In Cash | (908M) | 229M | 1.7B | (360M) | 3.3B | 3.5B | |
| Free Cash Flow | 8.5B | 9.9B | 8.4B | 8.8B | 7.4B | 4.5B | |
| Depreciation | 2.2B | 3.6B | 3.4B | 3.4B | 4.1B | 4.3B | |
| Other Non Cash Items | (186M) | (195M) | 1.3B | 1.3B | (991M) | (941.5M) | |
| Capital Expenditures | 618M | 608M | 880M | 936M | 1.1B | 663.6M | |
| Net Income | 7.8B | 7.3B | 5.9B | 6.6B | 6.7B | 3.4B | |
| End Period Cash Flow | 6.0B | 6.3B | 8.0B | 7.6B | 10.9B | 11.5B | |
| Change To Netincome | 205M | (152M) | 3.4B | 485M | 557.8M | 379.4M | |
| Investments | 20.0B | (4.7B) | 733M | (6.0B) | (2.6B) | (2.5B) | |
| Change Receivables | (504M) | (427M) | (429M) | (746M) | (671.4M) | (637.8M) | |
| Net Borrowings | (4.5B) | 2.5B | 795M | 6.6B | 6.0B | 6.3B | |
| Dividends Paid | 3.5B | 3.8B | 4.0B | 4.2B | 4.6B | 2.9B |
Pair Trading with Amgen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.Moving against Amgen Stock
| 0.86 | PAHC | Phibro Animal Health Financial Report 1st of May 2024 | PairCorr |
| 0.82 | CNTA | Centessa Pharmaceuticals Downward Rally | PairCorr |
| 0.81 | ANIP | ANI Pharmaceuticals Financial Report 13th of May 2024 | PairCorr |
| 0.78 | PBH | Prestige Brand Holdings Financial Report 2nd of May 2024 | PairCorr |
| 0.75 | OPT | Opthea | PairCorr |
The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.
The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Amgen Valuation and Amgen Correlation analysis. Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Amgen Stock analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.52) | Dividend Share 8.52 | Earnings Share 12.48 | Revenue Per Share 52.692 | Quarterly Revenue Growth 0.198 |
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.